ATYR

AS OF

Dec 12 closing price

Price

$0.78

Change

+$0.01 (+1.30%)

Capitalization

75.99M

89 days until earnings call

Intraday BUY SELL Signals

OUR PRODUCTS

MOBILE APPS

GENERAL INFO

Help

ATYR

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

aTyr Pharma (ATYR) Ownership - Who owns aTyr Pharma?

aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform... Show more

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Details

Group

Domestic Stock Funds

Fundamentals

ATYR

Capitalization

76M

P/E Ratio

N/A

Risk (Beta)

0.89

Dividend Yield

N/A

Total Cash

90.2M

Total Cash/Share

0.92

Total Debt

12.4M

Total Debt/Equity

N/A

Projected Growth (PEG Ratio)

N/A

Revenue/Share (as % of the share price)

0.00%

Revenue

190K

ROE

N/A

Book Value

80.2M

P/B Ratio

0.95

Cash Flow

N/A

Earnings

-0.83

Average Daily Volume YTD

N/A

Common Shares Outstanding - Security Level

98K

Current Ratio

5.93

Current Revenue Per Employee

3220.34

Dividends Per Share - Security

N/A

EBITDA

-77.49M

Float

N/A

Float - Current

N/A

Gross Income Margin

N/A

Revenue To Assets

-75.78

Shares Held By Institutions

124M

Shares Outstanding - Current

98M

Total Liabilities

26.6M

Total Volume MTD

N/A

Value

N/A

Gain YTD

-78.859

View a ticker or compare two or three

Compare

ATYR

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ATYR showed earnings on November 06, 2025. You can read more about the earnings report here.

View AI-Driven Trading for ATYR

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details